Dr. Reddy’s Labs drops 5% despite 1,257% sequential growth in Q1 profit; here's why
Dr. Reddy's posted a consolidated net profit of ₹1,187.6 crore in Q1FY23, registering a yearly growth of 108.05% and 1,257.25% on a quarterly basis.
dr reddys share price
July 2022
June 2022
Dr Reddy's rises 2% on deal to acquire Eton Pharma’s portfolio
Dr. Reddy's has acquired a portfolio of injectable products from Eton Pharma for an upfront payment of $5 million in cash, plus contingent payments of up to $45 million
